Topics

Companies Related to "A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis" [Most Relevant Company Matches] RSS

22:45 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis" found in our extensive corporate database of over 50,000 company records.

Showing "Study INCB050465 Combination With Ruxolitinib Subjects With Myelofibrosis" Companies 1–25 of 765

Relevant

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...


CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...


Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

International Pharmaceutical Research Center

International Pharmaceutical Research Center the commitment to unparalleled Quality Research. Our strength is our recognition from sponsors, investigators, and study subjects in conducting each study with dedication and a personal touch, while maintaining strict compliance with good clinical practice.

nTouch Research Corporation

nTouch Research Corporation is a leading provider of Phase II-IV clinical trials services delivering investigator selection, patient recruitment and study management services for pharmaceutical, CRO, and biotechnology industries.nTouch owns and operates 16 highly-rated research centers across the USA serving 250 private practice investigators. Our strength is our commitment to sponsors, investigat...

Roskilde University

Roskilde University is a state university founded in 1972 with the objective of providing research and education at the highest level in the fields of natural science, social science and the humanities. These activities at Roskilde University are organised in ten departments; degrees are offered in a wide range of subjects at Bachelor, Master and Ph.D. levels.Many study programmes are now being of...

RWTH Aachen University

RWTH Aachen University,Here, you will discover numerous opportunities offered at this university in the areas of research, teaching and study.The RWTH Aachen is characterised by its strength in science and engineering education. It also provides a wide range of subjects in Economics, Arts and Humanities and Medicine with an emphasis on intensive interaction between all disciplines. The focus on in...

MedAvante, Inc.

MedAvante is the premier global provider of centralized expert psychiatric rating and monitoring services to the pharmaceutical, biotechnology and medical device industries. Our flagship service, Remote Centralized Ratings are real-time assessments, either by telephone or videoconference, of subjects in global drug trials. Centralizing the assessors and blinding them to study protocols, results in...

Providence Clinical Research (PCR)

Providence Clinical Research (PCR) promotes the highest quality clinical research in the community setting. We provide support, training, oversight and tools to ensure the success of established and new clinical investigators. We advocate for study subjects, maintain the highest professional standards, and enable investigative site excellence

Atlantic Life Sciences, Inc

Atlantic Life Sciences, Inc., Provider of Tailored Clinical Services ALS Inc. is located in Montreal.It is one of the world-class CRO where the Experience, the Expertise and the Strategic Project Management create a value addition for the study success. Since its inception, Atlantic Life Sciences Inc. accomplishes clinical studies with a top quality. Each study is unique. Since 2003, ALS Inc. cond...

Clinical Research Associate

Clinical Research Associate, also known as a Monitor, is an individual that oversees the progress and conduct of a clinical trial. A clinical trial is usually implemented by physicians at a hospital, clinic, or physician's office. The CRA is required to oversee the initiation, progress, and conduct of the clinical trial to ensure the scientific integrity of the data collected, and the protection o...

Impact Biomedicines

Impact Biomedicines (“Impact”) is pioneering the development of life changing treatments for patients with complex cancers. The Company’s pipeline is centered around fedratinib, a potent and highly selective oral small molecule, JAK2 kinase inhibitor that is being developed initially for the treatment of myelofibrosis (MF) and polycythemia vera ...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...

University of Münster

The University of Münster is the third largest in Germany. Currently, about 39,000 students are enrolled and every year about 5,000 are graduating.The university's popularity is no doubt due to the wide range of subjects on offer (over 120), the excellence of the research carried out in many departments, and the high quality of life in the city of Münster.Münster University has an international...

Charles University Prague Faculty of Pharmacy

The Faculty of Pharmacy, Charles University, with its seat in the town of Hradec Kralove, was established by a government decree in 1969. This Faculty of Pharmacy has continued in the old and long-time tradition of the education of pharmacy at Charles University - the Prague pharmacists were connected with Charles Univesity from its foundation. (The owners of Prague pharmacies were enrolled in the...

Goodwyn IRB

Goodwyn means "good friend" and The Goodwyn IRB® is a good friend to pharmaceutical manufacturers, contract research organizations, site management organizations and the human subjects involved in clinical research studies.Actually, The Goodwyn IRB is a unique group of good friends – experts from all over North America, chosen for their expertise and reputation to provide the highest level of r...

Carbylan BioSurgery, Inc.

Carbylan (www.carbylan.com) was founded in 2005 to develop and market medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat...

Rapid Medical Research, Inc.

Rapid Medical Research, Inc., (RMR) is a free-standing, dedicated, multi-therapeutic clinical research center. Our professional research team includes an executive director, two physicians including a full-time onsite internist and 1 part-time OB/GYN, a regulatory specialist, four nurse coordinators, two patient recruiters, two research assistants, and an office manager. We offer a wide range of s...

Bioscience Association Manitoba

Read the study here: https://www.biomb.ca/news/reports/561/2019-bam-industry-profile-study

Association of Clinical Research Professionals

ACRP is the primary resource for clinical research professionals in the pharmaceutical, biotechnology, and medical device industries, as well as those in hospital, academic medical centers, and physician office settings. ACRP was founded in 1976 to address the distinct educational and networking needs of research nurses and others who supported the work of clinical investigations. With its own pro...

Imago BioSciences

Imago BioSciences is a clinical-stage, venture-backed pharmaceutical company focused on improving the management of proliferative diseases of the bone marrow and modulation of the immune system. The company is currently focused on neoplastic diseases of the bone marrow including acute myeloid leukemia, myelodysplastic syndrome, polycythemia vera, myelofibr...

Imago BioSciences, Inc.

Imago BioSciences is a clinical-stage, venture-backed pharmaceutical company focused on improving the management of proliferative diseases of the bone marrow and modulation of the immune system. The company is currently focused on neoplastic diseases of the bone marrow including acute myeloid leukemia, myelodysplastic syndrome, polycythemia vera, myelofibr...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Cytheris SA

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.  These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transp...


More From BioPortfolio on "A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis"

Quick Search

Corporate Database Quicklinks